Trending News
News
News
A Molecular Switch to Stop Inflammation
Researchers from Umeå University and University of Gothenburg have identified a molecular switch – MYSM1 – that can suppress such an overreaction and avoid inflammation.
News
Sleep Deprivation Affects Stem Cells, Reducing Transplant Efficiency
Although the research was done in mice, the findings have possible implications for bone marrow transplants, more properly called hematopoietic stem cell transplants, in humans.
News
Incyte and Merck Expand Clinical Collaboration
Pivotal study to evaluate Incyte’s IDO1 inhibitor in combination with Merck’s anti-PD-1 therapy in patients with advanced or metastatic melanoma.
News
CPhI Report Highlights Acquisitions of Niche Technologies
Medium term prospects for contract services remain positive (both developed and emerging markets), despite fragmented biosimilar regulation and GDUFA fees.
News
Lilly and ImaginAb Announce Preclinical Immuno-Oncology Collaboration
Collaboration to study potential novel T-cell-based immuno-oncology therapies.
News
IGI Laboratories to Acquire the Assets of Alveda Pharmaceuticals
Acquisition will deliver contribution to 2015 financial results.
News
enGene, Johnson & Johnson Collaborate
enGene, Inc. has announced that it has entered into a definitive agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to develop and commercialize new therapies for inflammatory bowel disease (IBD).
News
Rare Childhood Leukemia Reveals Surprising Genetic Secrets
A coalition of leukemia researchers led by scientists from UC San Francisco has discovered surprising genetic diversity in juvenile myelomonocytic leukemia (JMML), a rare but aggressive childhood blood cancer.
News
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
News
Crown Bioscience Expands Cardiovascular and Metabolic Disease Capabilities
Company has announced Zhen Pang as scientific director.
Advertisement